SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950129-04-009177
Filing Date
2004-11-19
Accepted
2004-11-19 06:04:06
Documents
6
Period of Report
2004-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMGEN INC.- NOVEMBER 15, 2004 a03515e8vk.htm 8-K 21705
2 EXHIBIT 4.2 a03515exv4w2.txt EX-4.2 71069
3 EXHIBIT 4.3 a03515exv4w3.txt EX-4.3 19787
4 EXHIBIT 4.4 a03515exv4w4.txt EX-4.4 19887
5 EXHIBIT 4.5 a03515exv4w5.txt EX-4.5 60702
6 EXHIBIT 10.1 a03515exv10w1.txt EX-10.1 70197
  Complete submission text file 0000950129-04-009177.txt   265827
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 041156267
SIC: 2836 Biological Products, (No Diagnostic Substances)